New directions for drug discovery.
Modern drug discovery demands an integrative approach, using many different technologies, but ultimately based on an understanding of the pathophysiology of the disease state to be treated. Targeting drugs at the main pathophysiological process is the key to success. This issue needs to be addressed with the multiple screening systems available, which can be used to find new leads.
Spedding
Michael
M
Experimental Sciences, Servier Research Institute, Suresnes, France. michael.spedding@fr.netgrs.com
D000818:Animals; D002986:Clinical Trials as Topic; D017277:Drug Approval; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D010600:Pharmacology / Q000639:trends*; D011619:Psychotropic Drugs / Q000494:pharmacology
D011619:Psychotropic Drugs